Skip to main content

Advertisement

Table 1 Subject’s general clinical characteristics for obese and lean groups

From: Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects

  Control n Normoinsulinemic n Hyperinsulinemic n p p1 p2 p3
  (LS)   (NI)   (HI)    LSvs. NI LSvs. HI NIvs. HI
M/F* 4/9 13 2/13 15 5/7 12 ns - - -
Age (years) 33 ± 12 13 29 ± 7 15 29 ± 8 12 ns ns ns ns
Body mass (Kg) 63.71 ± 8.98 13 95.67 ± 12.78 15 103.464 ± 12.89 12 0.0001 0.0001 0.0001 ns
Height (m) 1.66 ± 0.10 13 1.63 ± 0.09 15 1.69 ± 0.09 12 ns ns ns ns
BMI (kg/m2) 22.92 ± 2.03 13 35.25 ± 3.80 15 37.05 ± 3.88 12 0.0001 0.000 0.0001 ns
Fat mass (kg) 18.66 ± 3.98 13 36.70 ± 7.15 15 40.80 ± 9.24 12 0.0001 0.0001 0.0001 ns
Lean mass (kg) 41.49 ± 6.02 13 57.22 ± 8.02 15 63.76 ± 10.12 12 0.0001 0.0001 0.0001 ns
Body water (%) 48.77 ± 4.98 13 41.34 ± 5.16 15 42.04 ± 4.72 12 0.006 0.004 0.008 ns
Basal metabolic rate (kcal) 1261.3 ± 183.53 13 1740 ± 244.07 15 1938.45 ± 307.62 12 0.0001 0.000 0.0001 ns
  1. M/F male/female; BMI body mass index; Values are means ± DP; P values for comparison between groups by non-parametric analysis of Kruskal Wallis; *P values for comparison between groups by non-parametric analysis descriptive of Chi-Square; P, comparing all groups. P1, P2 and P3 comparison between groups.